Size characterization of plasmonic nanoparticles with dark-field single particle spectrophotometry
New publication at Mecwins A new article [...]
Montserrat Calleja Gómez, co-founder of Mecwins SA, receives the Rei Jaume I Award of New Technology
Montserrat Calleja Gómez has been recognized for her [...]
Jesús Javier Cía Barrio, chosen as one of the best lawyers in Spain
Three lawyers from Pamplona selected as the top three [...]
Mecwins has been granted with more than 1.4M€ to develop ultrasensitive optoplasmonic immunoassays for the early detection of breast cancer under the Líneas Estratégicas Program
Mecwins, in collaboration with the Bionanomechanics Lab from [...]
Developing ‘Highly Sensitive’ Plasmonic Testing Tech
Mecwins Developing 'Highly Sensitive' Plasmonic Testing Tech for Laboratories, Point [...]
€4 million injection to help boost Mecwins’s position on the early diagnosis market
Mecwins has signed a financial agreement with its investor [...]
Mecwins Announces Strategic Partnership to Develop a Next Generation Platform for Point of Care (POC) Testing
This licensing and co-development agreement leverages Mecwins’ ultrasensitive AVAC [...]
Mecwins signs a R&D agreement with IRYCIS
Óscar Ahumada, PhD, CEO of Mecwins, has recently [...]
Our scientific promoter Prof. Javier Tamayo ranked among the top 2% most-cited researchers in the world
Our scientific promoter Prof. Javier Tamayo, leader of the Bionanomechanics Lab [...]
Mecwins continues to sponsor “Club Triatlón Canto Blanco”
Mecwins is still one of the proud sponsors of [...]
